JRJosé Antonio Rodríguez-García

José Antonio Rodríguez-García

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Antonio Rodríguez-García has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies

    by Fernando Ramos, Paola González-Carmona, María Isabel Porras-Guerra, Sonia Jiménez-Mola, Ana María Martínez-Peláez, Agustín Blanco-Cabielles, Saray Conde, Abdolah Ahmadi, Marta Castellanos, Seila Cerdá, et al.

    Several societies have published recommendations for evaluating older adults with cancer in standard conditions. It is vital to assure a proper systematic patient condition evaluation, not only in the oldest (geriatric assessment) but in all adult patients. We have investigated the feasibility of a systematic evaluation of the general condition of all patients diagnosed with hematologic malignancies, and the degree of acceptance by the clinical team, in a prospective cohort of 182 consecutive adults, by using the ECOG performance status scale (ECOG, age 18 and over, 18+), Lee Index for Older Adults (LEE, 50+), Geriatric Assessment in Hematology (GAH, 65+), and the Comprehensive Geriatric Assessment (CGA, 75+). Clinical team acceptance was analyzed with a visual analogue scale, and the objective feasibility was calculated as the proportion of patients that could be finally evaluated with each tool. Acceptance was high, but the objective feasibility was progressively lower as the complexity of the different tools increased (ECOG 100%, LEE 99.4%, GAH 93.2%, and CGA 67.9%). LEE and GAH categories showed a weak concordance (Cohen’s Kappa 0.24) that was slight between LEE and CGA (Kappa 0.18). Unexpectedly, we found no significant association between the GAH and CGA categories (p = 0.16). We confirm that a systematic evaluation of all adult patients diagnosed with hematologic malignancies is feasible in daily practice by using an age-adapted approach. Direct comparisons among the different predictive tools in regard to patients’ tolerance to treatments of different intensities must be a priority research subject in the coming years.


  • Tratamiento de la hemofilia adquirida en el paciente anciano. Estudio de 10 casos

    by José Antonio Rodríguez-García, Violeta Martínez-Robles, Belén Pérez-Gutiérrez


  • Treatment of acquired haemophilia in the elderly. Study of 10 cases

    by José Antonio Rodríguez-García, Violeta Martínez-Robles, Belén Pérez-Gutiérrez

  • Incidence of haematological neoplasms in Castilla y León, Spain

    by José Antonio Rodríguez-García, Lourdes Vázquez, Fernando Ramos, Beatriz Cuevas, Alejandro Martín, Alicia Smucler, Dulce Nombre Guerola, Alberto Cantalapiedra, José María Alonso, Silvia Fernández, et al.


  • Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León

    by José Antonio Rodríguez-García, Lourdes Vázquez, Fernando Ramos, Beatriz Cuevas, Alejandro Martín, Alicia Smucler, Dulce Nombre Guerola, Alberto Cantalapiedra, José María Alonso, Silvia Fernández, et al.


  • Open Access

    High incidence of acute leukemia in the proximity of some industrial facilities in El Bierzo, northwestern Spain

    by José Antonio Rodríguez-García, Fernando Ramos

    To estimate the incidence of acute leukemia (AL) in El Bierzo (BZ) and to carry out a cross-association analysis in order to suggest some etiological clues. We registered all new AL cases diagnosed 2000–2005. Annual standardized incidence rate (SIR) was calculated by the direct method. A cross-association analysis was performed by non-parametric methods and we checked the potential interaction between putative etiological factors by calculating Chi-square-for-trend. SIR was 5.1 cases per 100 000, surpassing the Spanish, European and world average figures and heterogeneous throughout the region. We detected a negative correlation between acute myeloblastic leukemia (AML) SIR in every municipality and both the air distance to the nearest thermoelectric power plant (TPP) (Rho = −0.409; p = 0.01) and to the point of maximum density of the high-power lines (HPL) network (Rho = −0.329; p = 0.04). Accordingly, SIR was higher in the municipalities situated < 7.5 km away from TPP (9.58 vs. 1.72; p = 0.004) or < 10 km away from HPL (3.90 vs. 3.19; p = 0.045). A positive relation between both factors was observed (Chi-square-for-trend = 9.209; p = 0.006). SIR of AL in BZ is higher than the Spanish average and that of most countries in the world. Residing near TPP or HPL confers a higher risk of AML, with synergistic effect between both factors.


  • Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

    by Ramón García‐Sanz, Silvia Montoto, Agustín Torrequebrada, Alfonso García De Coca, José Petit, Anna Sureda, José Antonio Rodríguez‐García, Pilar Massó, Ana Pérez‐Aliaga, María Dolores Monteagudo, et al.

    In this report we analyse the presenting features of a series of patients diagnosed with Waldenström macroglobulinaemia (WM) in Spain over the last 10 years. Criteria for diagnosis required a serum monoclonal IgM protein 30 g/l and > 20% bone marrow lymphocytes. Two hundred and seventeen patients were included in the study, with a median age of 69 years and male/female ratio of 2:1. The most common symptoms at diagnosis were anaemia (38%), hyperviscosity (31%), B symptoms (23%), bleeding (23%) and neurological symptoms (22%). Sixty‐one patients (27%) were asymptomatic at diagnosis and, to date, 32 of them have not received chemotherapy. Variables predicting a shorter survival free of therapy were haemoglobin < 12·5 g/dl and high β2microglobulin (β2M). The 83% of patients who did receive treatment were distributed as follows: chlorambucil/prednisone (43%), intermittent chlorambucil (11%), continuous chlorambucil (26%), cyclophosphamide/vincristine/prednisone (COP, 13·5%) and other (6·5%). Response to therapy was complete in 2%, partial in 48% and minor in 10%. Finally, 28% and 13% of patients presented stable and progressive disease, respectively, which was more common among patients treated with COP. Progression‐free survival was 43% at 5 years, with three independent predictors for shorter progression‐free survival (PFS): COP treatment, age > 65 and B symptoms at diagnosis. The 10‐year projected overall survival (OS) was 55%. The two most frequent causes of death were development of second malignancies (31%), or infections (19%). The two main variables predicting a poor OS were hyperviscosity and high β2M. In summary, this study favours the use of chlorambucil‐based therapy as the standard treatment for WM, and describes a subset of patients who should be considered as suffering a smouldering form and who therefore do not require treatment for a long period of time.


    • 1 December 1999
      • Vol. 44  (6) , 491-2

    [Attenuated Fechtner syndrome: presentation of a new case with some variants].

    by J A Rodríguez García, M Megido Lahera

    • 1 July 1997
      • Vol. 50  (6) , 649-54

    [Simplified Ramírez urethropexy in the treatment of genuine stress urinary incontinence in women. Multicenter study of clinical and urodynamic results].

    by J C Ramírez Fernández, M E Fuertes, J Salinas Casado, L Resel Estévez, M Sánchez Chapado, M Guil Cid, F Rodríguez De Bethancourt Codes, L Prieto Chaparro, G Shahrour, R Ocete Ocete, et al.

    To evaluate the clinical and urodynamic data of a multicenter study on female urinary stress incontinence undergoing surgical repair with the Ramírez simplified urethropexy. Clinical, urodynamic and videocystographic data were analyzed in a multicenter series of 340 female patients with urinary stress incontinence (mean age 51.7 +/- 9.7 years) before and after the Ramírez urethropexy technique (mean follow-up 21.7 months). Post surgical urinary continence was 78.4%. Cystocele repair was demonstrated in 57.7%. Urge incontinence decreased in 17.1%. Daytime frequency statistically significantly decreased in 19%. Urinary obstructive symptoms increased in 19.3%. Bladder instability significantly decreased posturethropexy. Peak urinary flow rate and mean urinary flow rate diminished in 65% and 59%, respectively. Postvoiding residual urine increased significantly. No statistical correlation between posturethropexy continence and videocystographic bladder neck morphology was observed. The clinical and urodynamic data obtained in our series indicate that the Ramírez urethropexy technique, a simple and fast procedure, may be considered an alternative treatment in female urinary stress incontinence.